CXT vs ENOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

CXT

33.6
AI Score
VS
ENOV Wins

ENOV

36.2
AI Score

Investment Advisor Scores

CXT

34score
Recommendation
SELL

ENOV

36score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CXT ENOV Winner
Revenue 880.90M 1.17B ENOV
Net Income 41.80M -9.95M CXT
Net Margin 4.7% -0.8% CXT
Operating Income 91.10M 23.94M CXT
ROE 3.3% -0.7% CXT
ROA 1.2% -0.3% CXT
Total Assets 3.60B 3.77B ENOV
Cash 231.40M 12.56M CXT
Debt/Equity 1.00 0.87 ENOV
Current Ratio 1.42 1.98 ENOV

Relative Price Performance (Last 90 Days)

CXT 1M: +20.3% · 3M: +10.2% ENOV 1M: +18.4% · 3M: -20.1%

Current Technical Phase

CXT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 75

RSI (14): 75.1 · Price: $58.23

ENOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 66

RSI (14): 65.7 · Price: $21.59

Fundamentals Snapshot

Metric CXT ENOV
Market Cap — —
Forward P/E 12.3 6.1
Trailing P/E 23.3 —
Revenue (TTM) — —
Revenue Growth 0.2% 0.0%
Gross Margin 0.4% 0.6%
Operating Margin 0.2% 0.0%
EPS 2.41 -19.23
Dividend Yield 0.01% —

Frequently Asked Questions

Based on our detailed analysis, ENOV is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.